NM_020384.4:c.265G>A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020384.4(CLDN2):​c.265G>A​(p.Ala89Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000000911 in 1,098,222 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 9.1e-7 ( 0 hom. 1 hem. )

Consequence

CLDN2
NM_020384.4 missense

Scores

5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.61
Variant links:
Genes affected
CLDN2 (HGNC:2041): (claudin 2) This gene product belongs to the claudin protein family whose members have been identified as major integral membrane proteins localized exclusively at tight junctions. Claudins are expressed in an organ-specific manner and regulate tissue-specific physiologic properties of tight junctions. This protein is expressed in the intestine. Alternatively spliced transcript variants with different 5' untranslated region have been found for this gene.[provided by RefSeq, Jan 2010]
MORC4 (HGNC:23485): (MORC family CW-type zinc finger 4) In human, the four current members of the microrchidia (morc) gene family share an N-terminal ATPase-like ATP-binding region and a CW four-cysteine zinc-finger motif. The protein encoded by this gene also has a nuclear matrix binding domain and a two-stranded coiled-coil motif near its C-terminus. This gene is widely expressed at low levels in normal tissues and has elevated expression in placenta and testis. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23800337).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLDN2NM_020384.4 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 ENST00000336803.2 NP_065117.1 P57739
CLDN2NM_001171092.1 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 NP_001164563.1 P57739
CLDN2NM_001171095.2 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 NP_001164566.1 P57739

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLDN2ENST00000336803.2 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 2 NM_020384.4 ENSP00000336571.1 P57739
CLDN2ENST00000540876.1 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 1 ENSP00000443230.1 P57739
CLDN2ENST00000541806.6 linkc.265G>A p.Ala89Thr missense_variant Exon 2 of 2 1 ENSP00000441283.1 P57739
MORC4ENST00000604604.1 linkc.110+64737C>T intron_variant Intron 1 of 1 2 ENSP00000474750.1 S4R3U3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1098222
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
1
AN XY:
363576
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000331
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 02, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.265G>A (p.A89T) alteration is located in exon 2 (coding exon 1) of the CLDN2 gene. This alteration results from a G to A substitution at nucleotide position 265, causing the alanine (A) at amino acid position 89 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.42
T;T;T
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.70
T;.;.
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.24
T;T;T
MetaSVM
Uncertain
0.012
D
MutationAssessor
Benign
2.0
M;M;M
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.52
N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.032
D;D;D
Sift4G
Benign
0.068
T;T;T
Polyphen
0.035
B;B;B
Vest4
0.14
MutPred
0.54
Gain of glycosylation at A89 (P = 0.0308);Gain of glycosylation at A89 (P = 0.0308);Gain of glycosylation at A89 (P = 0.0308);
MVP
0.87
MPC
0.53
ClinPred
0.62
D
GERP RS
3.6
Varity_R
0.15
gMVP
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-106171723; API